Trials / Sponsors / Eirion Therapeutics Inc.
Eirion Therapeutics Inc.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study to Evaluate AI-09 In Participants With Glabellar Lines Glabellar Lines | Phase 2 | 2025-12-03 |
| Completed | AI-09 In Subjects With Glabellar Lines, GL-101 Glabellar Frown Lines | Phase 1 / Phase 2 | 2022-09-03 |
| Completed | ET-01 in Subjects With Lateral Canthal Lines, LCL-210 Lateral Canthal Lines, LCL, Crow's Feet | Phase 2 | 2021-07-19 |
| Completed | ET-01 in Subjects With Lateral Canthal Lines, LCL-209 Lateral Canthal Lines, LCL, Crow's Feet | Phase 2 | 2019-02-27 |
| Completed | ET-01 in Subjects With Lateral Canthal Lines, LCL-208 Lateral Canthal Lines, Crow's Feet | Phase 2 | 2018-10-16 |
| Completed | ET-01 in Subjects With Lateral Canthal Lines, LCL-207 Lateral Canthal Lines, Crow's Feet | Phase 2 | 2018-08-16 |
| Completed | ET-01 in Subjects With Lateral Canthal Lines Lateral Canthal Lines, Crow's Feet | Phase 2 | 2017-10-25 |